Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
12.56
-0.92 (-6.82%)
At close: Apr 1, 2025, 4:00 PM
12.62
+0.06 (0.46%)
After-hours: Apr 1, 2025, 7:55 PM EDT

Viridian Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
1,0231,5191,1451,17642964
Upgrade
Market Cap Growth
32.58%32.58%-2.58%173.76%568.00%321.43%
Upgrade
Enterprise Value
32997798989237944
Upgrade
Last Close Price
12.5619.1721.7829.2119.7716.45
Upgrade
PS Ratio
3388.915028.173647.53663.46144.9461.23
Upgrade
PB Ratio
2.112.262.592.982.290.54
Upgrade
P/TBV Ratio
3.153.154.864.657.97-
Upgrade
EV/Sales Ratio
1089.363236.513150.76503.65127.7941.48
Upgrade
Debt / Equity Ratio
0.030.030.050.010.000.00
Upgrade
Asset Turnover
000.000.010.020.01
Upgrade
Quick Ratio
14.9914.9917.9312.7314.4811.96
Upgrade
Current Ratio
15.4315.4318.2712.9314.6812.14
Upgrade
Return on Equity (ROE)
-48.48%-48.48%-56.80%-44.57%-51.61%-163.07%
Upgrade
Return on Assets (ROA)
-30.32%-30.32%-34.37%-26.28%-29.75%-31.36%
Upgrade
Return on Capital (ROIC)
-32.26%-32.26%-36.80%-28.52%-32.28%-35.04%
Upgrade
Earnings Yield
-20.38%-17.78%-20.76%-11.05%-18.49%-172.21%
Upgrade
FCF Yield
-22.75%-15.33%-16.16%-8.05%-12.79%-46.39%
Upgrade
Buyback Yield / Dilution
-51.68%-51.68%-39.48%-169.22%-235.07%-70.27%
Upgrade
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q